4-methoxyamphetamine has been researched along with Disease Exacerbation in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.38) | 18.7374 |
1990's | 2 (4.76) | 18.2507 |
2000's | 13 (30.95) | 29.6817 |
2010's | 24 (57.14) | 24.3611 |
2020's | 2 (4.76) | 2.80 |
Authors | Studies |
---|---|
Caskey, FJ; Chesnaye, NC; de Rooij, ENM; Dekker, FW; Drechsler, C; Evans, M; Heimburger, O; Jager, KJ; Pippias, M; Porto, G; Szymczak, M; Torino, C; Wanner, C | 1 |
Akkerhuis, KM; Baart, S; Boersma, E; Bouwens, E; Caliskan, K; Constantinescu, AA; Cornel, JH; de Maat, M; Kardys, I; Manintveld, OC; Mouthaan, H; Umans, VAWM; van den Berg, VJ | 1 |
Maes, E; Oliver, DJ; Vanopdenbosch, LJ | 1 |
Alter, DA | 1 |
Chonchol, M; Gitomer, B; Gupta, M; Nowak, KL; You, Z | 1 |
Graham, RB; Hofer, SM; Karr, JE; Muniz-Terrera, G | 1 |
Bartlett, C; Irving, L; Luthe, M; Ong, J; Ross, L; Smallwood, N; Taverner, J | 1 |
Lee, GL; Ramaswamy, A | 1 |
Citerio, G; Iaquaniello, C; Robba, C | 1 |
Alkukhun, L; Baumgartner, M; Dweik, RA; Minai, OA; Tonelli, AR | 1 |
Boucquemont, J; Combe, C; Leffondre, K; Metzger, M; Stengel, B | 1 |
Hermerén, G; Hoff, L | 2 |
Arsenault, BJ; Bossé, Y; Capoulade, R; Chan, KL; Després, JP; Dumesnil, JG; Mahmut, A; Mathieu, P; Pibarot, P; Tam, JW; Teo, KK; Tsimikas, S; Witztum, JL; Yang, X; Yeang, C | 1 |
Bouché, O; Ducreux, M; Ferrer, L; Król, A; Michiels, S; Pignon, JP; Proust-Lima, C; Rondeau, V | 1 |
Hawkes, N | 1 |
Haneuse, S; Jazić, I; Sargent, DJ; Schrag, D | 1 |
Flaherty, KR; Murray, S | 1 |
Alyea, EP; Antin, JH; Armand, P; Carlton, VE; Chen, YB; Cutler, CS; Faham, M; Herrera, AF; Ho, VT; Kim, HT; Kong, KA; Koreth, J; Kotwaliwale, C; Nikiforow, S; Ritz, J; Rodig, SJ; Sohani, AR; Soiffer, RJ; Sun, H | 1 |
Flaxman, AD; Hernandez, B; Joshi, R; Lopez, AD; Mooney, MD; Murray, CJ; Praveen, D; Riley, I; Sanvictores, D; Serina, P; Stewart, A; Tallo, V | 1 |
Abramson, MJ; Drummer, OH; Elliot, JG; James, AL; Walters, EH | 1 |
Buijs, C; de Vries, EG; le Cessie, S; Post, WJ | 1 |
Bourgoun, M; Califf, RM; Ghali, JK; Hassanein, AH; Hung, CL; Køber, L; Pfeffer, MA; Shin, SH; Solomon, SD; Uno, H; Velazquez, EJ; Verma, A | 1 |
Doherty, D; Nathan, E; Patole, S; Srinivasjois, R | 1 |
Fujiwara, M; Kato, Y; Mimura, A; Shiode, N; Shirota, K; Tsunoda, F | 1 |
Brayne, C; Matthews, FE; Muniz-Terrera, G; Stephan, B | 1 |
Anastasiou-Nana, M; Apostolou, T; Charalampopoulos, A; Dagres, N; Kotakos, C; Liakos, G; Rallidis, LS; Sourides, V; Varounis, C | 1 |
Efstathopoulos, N; Georgitsi, M; Giamarellos-Bourboulis, EJ; Koutsostathis, S; Lallos, S; Roumeliotis, L; Tsaganos, T | 1 |
Powell, LH; Shahabi, L; Thoresen, CE | 1 |
MOORE, AE; PATTI, J | 1 |
Bangsberg, DR; Charlebois, E; Clark, R; Guzman, D; Kagay, CR; Liechty, CA; Moss, AR; Porco, TC | 1 |
Alford, MF; Emery, SC; Hansen, LA; Reid, RT; Sabbagh, MN; Thal, LJ; Tiraboschi, P; Tyas, SL | 1 |
Falk, V; Gummert, JF; Hambrecht, R; Jacobs, S; Mohr, FW; Oettel, S; Schuler, G; Sick, P; Thiele, H | 1 |
Atkinson, MA; Campbell-Thompson, M; Clarke, T; Croker, B; Glushakova, O; Heinig, M; Johnson, RJ; Nakagawa, T; Sato, W; Yuzawa, Y | 1 |
Ritchie, LJ; Tuokko, H | 1 |
Reb, AM | 1 |
Berryman, S; Kasarskis, EJ; McClain, CJ; Schneider, AR; Vanderleest, JG | 1 |
Legrand, M | 1 |
McQuay, HJ; Moore, RA; Reynolds, DJ; Tramèr, MR | 1 |
Borasio, GD; Neudert, C; Oliver, D; Wasner, M | 1 |
Christakis, NA; Iwashyna, TJ | 1 |
Fennell, ML; Mor, V; Teno, JM; Weitzen, S | 1 |
3 review(s) available for 4-methoxyamphetamine and Disease Exacerbation
Article | Year |
---|---|
When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Death; Dementia; Disease Progression; Female; Humans; Male; Neuropsychological Tests | 2018 |
Death by neurologic criteria: pathophysiology, definition, diagnostic criteria and tests.
Topics: Apnea; Brain; Brain Death; Brain Injuries; Brain Stem; Coma; Death; Diabetes Insipidus; Diagnosis, Differential; Disease Progression; Electrodiagnosis; Heart Arrest; Hemodynamics; Hypothalamo-Hypophyseal System; Neuroimaging; Neurologic Examination; Reflex, Abnormal; Reflex, Pupillary; Sympathetic Nervous System | 2019 |
Religion and spirituality. Linkages to physical health.
Topics: Cardiovascular Diseases; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Death; Disease Progression; Health Status; Humans; Morbidity; Mortality; Neoplasms; Religion and Medicine; Risk Factors; Spirituality | 2003 |
3 trial(s) available for 4-methoxyamphetamine and Disease Exacerbation
Article | Year |
---|---|
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Biomarkers; Calcinosis; Death; Disease Progression; Female; Humans; Lipoprotein(a); Male; Middle Aged; Oxidation-Reduction; Phospholipids; Ultrasonography | 2015 |
Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma.
Topics: Adolescent; Adult; Aged; Death; Disease Progression; DNA, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins; Lymphoma; Male; Middle Aged; Neoplasm, Residual; Receptors, Antigen, T-Cell; Recurrence; Retrospective Studies; Sequence Analysis, DNA; Transplantation, Homologous; Treatment Outcome; Young Adult | 2016 |
Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: a 5-year follow-up.
Topics: Aged; Coronary Artery Bypass; Coronary Stenosis; Death; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Stents | 2005 |
36 other study(ies) available for 4-methoxyamphetamine and Disease Exacerbation
Article | Year |
---|---|
Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD.
Topics: Aged; Death; Disease Progression; Glomerular Filtration Rate; Hospitalization; Humans; Prospective Studies; Quality of Life; Renal Insufficiency, Chronic | 2023 |
Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Death; Disease Progression; Female; Fibrinolysis; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Longitudinal Studies; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prognosis; Receptors, Urokinase Plasminogen Activator; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2019 |
European Academy of Neurology/European Association for Palliative Care Taskforce on Neurology Consensus recommendations on palliative care for patients with chronic and progressive neurological disease - acceptability for Belgian neurologists.
Topics: Belgium; Chronic Disease; Consensus; Death; Disease Progression; Europe; Family; Health Care Surveys; Nervous System Diseases; Neurologists; Palliative Care; Patient Care Team; Surveys and Questionnaires | 2017 |
Tracking Our Physical Inactivity and Progression to Death: Is This Evolutionary Stagnation?
Topics: Death; Disease Progression; Exercise; Humans | 2017 |
Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
.
Topics: Adolescent; Adult; Aged; Child; Death; Disease Progression; Fathers; Female; Genotype; Humans; Hypertension; Kaplan-Meier Estimate; Kidney Failure, Chronic; Longitudinal Studies; Male; Middle Aged; Mothers; Polycystic Kidney, Autosomal Dominant; Retrospective Studies; Severity of Illness Index; Sex Factors; Survival Rate; Time Factors; TRPP Cation Channels; Young Adult | 2018 |
Antimicrobial prescription in patients dying from chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Australia; Azithromycin; Ceftriaxone; Death; Disease Progression; Female; Guideline Adherence; Hospitalization; Humans; Logistic Models; Male; Medical Audit; Palliative Care; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Retrospective Studies | 2019 |
Physical, psychological, social, and spiritual aspects of end-of-life trajectory among patients with advanced cancer: A phenomenological inquiry.
Topics: Aged; Death; Disease Progression; Female; Follow-Up Studies; Health Services Needs and Demand; Home Care Services; Hospice Care; Humans; Male; Middle Aged; Neoplasms; Qualitative Research; Spirituality; Terminally Ill | 2020 |
Electrocardiography at diagnosis and close to the time of death in pulmonary arterial hypertension.
Topics: Death; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Male; Middle Aged | 2014 |
Should we use standard survival models or the illness-death model for interval-censored data to investigate risk factors of chronic kidney disease progression?
Topics: Adult; Aged; Creatinine; Death; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kidney Transplantation; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index | 2014 |
Identifying challenges to communicating with patients about their imminent death.
Topics: Adult; Aged; Attitude of Health Personnel; Attitude to Death; Communication; Comprehension; Death; Disease Progression; Female; Humans; Leukemia; Lung Neoplasms; Male; Middle Aged; Multiple Myeloma; Neoplasms; Palliative Care; Physician-Patient Relations; Physicians; Practice Guidelines as Topic; Prognosis; Recurrence; Remission Induction; Truth Disclosure; Withholding Treatment | 2014 |
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Computer Simulation; Death; Disease Progression; Humans; Longitudinal Studies; Models, Statistical; Neoplasm Metastasis; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Tumor Burden | 2016 |
Dogs died in studies of drug that killed man in French trial.
Topics: Animals; Brain; Brain Diseases; Clinical Trials as Topic; Death; Disease Models, Animal; Disease Progression; Dogs; France; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Prognosis; Severity of Illness Index; Skull Base; Terfenadine | 2016 |
Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomedical Research; Clinical Trials as Topic; Colorectal Neoplasms; Computer Simulation; Death; Disease Progression; Disease-Free Survival; Endpoint Determination; Humans; Models, Statistical; Neoplasm Metastasis; Risk Assessment | 2016 |
Clinical Trial Design Based on Time to Death/Progression.
Topics: Clinical Trials as Topic; Death; Disease Progression; Humans | 2016 |
The paradox of verbal autopsy in cause of death assignment: symptom question unreliability but predictive accuracy.
Topics: Adult; Autopsy; Cause of Death; Child; Death; Disease Progression; Family; Humans; Infant, Newborn; Philippines; Reproducibility of Results; Surveys and Questionnaires; Vital Statistics | 2016 |
Time to death and mast cell degranulation in fatal asthma.
Topics: Adolescent; Adult; Asthma; Australia; Cell Degranulation; Child; Death; Disease Progression; Female; Humans; Lung; Male; Mast Cells; Middle Aged; Muscle Contraction; Muscle, Smooth; Predictive Value of Tests; Prognosis; Risk Factors; Severity of Illness Index; Time Factors; Young Adult | 2009 |
Analyzing longitudinal data with patients in different disease states during follow-up and death as final state.
Topics: Algorithms; Antineoplastic Agents; Breast Neoplasms; Computer Simulation; Death; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Health Status; Humans; Longitudinal Studies; Models, Statistical; Multicenter Studies as Topic; Netherlands; Probability; Proportional Hazards Models; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Regression Analysis; Surveys and Questionnaires | 2009 |
Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both.
Topics: Aged; Analog-Digital Conversion; Angiotensin II Type 1 Receptor Blockers; Death; Disease Progression; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Motion; Myocardial Contraction; Myocardial Infarction; Prognosis; Proportional Hazards Models; Stress, Mechanical; Tetrazoles; Ultrasonography; Valine; Valsartan; Ventricular Dysfunction, Left; Video Recording | 2010 |
Prediction of progression of definite necrotising enterocolitis to need for surgery or death in preterm neonates.
Topics: Birth Weight; Death; Digestive System Surgical Procedures; Disease Progression; Enterocolitis, Necrotizing; Female; Health Services Needs and Demand; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Prognosis; Retrospective Studies | 2010 |
Late progression after sirolimus-eluting stent implantation for de novo lesions--comparison with bare metal stent implantation.
Topics: Aged; Aged, 80 and over; Constriction, Pathologic; Death; Disease Progression; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2010 |
Are terminal decline and its potential indicators detectable in population studies of the oldest old?
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Brief Psychiatric Rating Scale; Cognition Disorders; Cohort Studies; Death; Disease Progression; Female; Humans; Male; Risk Factors | 2011 |
Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Artery Disease; Death; Depression; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prevalence; Prognosis; Severity of Illness Index; Time Factors | 2011 |
Between uncertainty and certainty.
Topics: Adult; Aged; Communication; Death; Decision Making; Disease Progression; Female; Humans; Life Support Care; Male; Middle Aged; Narration; Recurrence; Surveys and Questionnaires; Truth Disclosure; Uncertainty; Withholding Treatment | 2011 |
Early increase of serum angiopoietin-2 are associated with early progression to death in experimental injury.
Topics: Anesthesia; Angiopoietin-2; Animals; Blood Pressure; Death; Diastole; Disease Progression; Femur; Male; Malondialdehyde; Rabbits; Survival Analysis; Systole; Tumor Necrosis Factor-alpha | 2011 |
Heterologous growth of sarcoma 180 with progression to death of hosts.
Topics: Animals; Death; Disease Progression; Humans; Neoplasms; Sarcoma; Sarcoma 180 | 1950 |
Modeling the impact of modified directly observed antiretroviral therapy on HIV suppression and resistance, disease progression, and death.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Death; Directly Observed Therapy; Disease Progression; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Models, Statistical; Patient Compliance | 2004 |
Smoking affects the phenotype of Alzheimer disease.
Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Brain; Causality; Death; Disease Progression; Educational Status; Female; Genotype; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Phenotype; Prospective Studies; Sex Factors; Smoking | 2005 |
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
Topics: Animals; Death; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Insulin; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Vascular Endothelial Growth Factor A | 2007 |
Neuropsychological prediction of attrition due to death.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Chi-Square Distribution; Cognition Disorders; Death; Dementia; Disease Progression; Female; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Predictive Value of Tests | 2007 |
Transforming the death sentence: elements of hope in women with advanced ovarian cancer.
Topics: Adaptation, Psychological; Adult; Aged; Death; Disease Progression; Female; Humans; Interviews as Topic; Middle Aged; Ovarian Neoplasms | 2007 |
Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Anthropometry; Body Composition; Body Mass Index; Cations; Death; Dietary Proteins; Disease Progression; Energy Intake; Energy Metabolism; Female; Humans; Male; Middle Aged; Nitrogen; Nutritional Status | 1996 |
[Communicating the worsening condition or death of a patient].
Topics: Communication; Death; Disease Progression; Humans; Professional-Family Relations; Terminal Care | 1997 |
Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Databases, Factual; Death; Disease Progression; Endoscopy, Digestive System; Gastrointestinal Hemorrhage; Humans; Models, Statistical; Peptic Ulcer Perforation; Risk Assessment | 2000 |
The course of the terminal phase in patients with amyotrophic lateral sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Amyotrophic Lateral Sclerosis; Anxiety; Caregivers; Cough; Death; Disease Progression; Dyspnea; Fear; Female; Health Surveys; Humans; Male; Middle Aged; Palliative Care; Quality of Life; Retrospective Studies; Terminal Care | 2001 |
Signs of death.
Topics: Death; Disease Progression; Hospice Care; Humans; Neoplasms; Prognosis; United States | 2001 |
Dying trajectory in the last year of life: does cancer trajectory fit other diseases?
Topics: Activities of Daily Living; Data Collection; Death; Death Certificates; Diabetes Mellitus; Disease Progression; Heart Failure; Hospice Care; Humans; Neoplasms; Prognosis; Pulmonary Disease, Chronic Obstructive; Stroke; United States | 2001 |